- Let's make a deal May 6
There's been a high-stakes reshuffling of the deck in the global pharmaceutical industry, and the latest company to show its hand is Germany's Bayer, which said Tuesday morning that it's purchasing Merck's consumer care unit for $14.2 billion. That means the company that pioneered aspirin — and now also makes Alka-Seltzer, Aleve, and Flintstones vitamins, among other brands — will own Claratin, Afrin, Coppertone, and Dr. Scholl's foot products. But the bigger prize for Bayer, assuming the deal goes through, is that it will be the No. 2 consumer drugmaker in the world, after Johnson & Johnson.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Why Pakistan won't hunt down the terrorists within its borders
- 43 TV shows to watch in 2014
- Sorry, GOP, tax cuts don't pay for themselves
- Pope Francis' American problem
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- What would a U.S.-Russia war look like?
- How academia's liberal bias is killing social science
- Alien conspiracy theorists think the government is on the verge of spilling big secrets
- How to develop a photographic memory in 4 easy steps
- 12 holiday gifts for the hardest-to-shop-for people on your list
Subscribe to the Week